Skip to content

Can PKU start in adulthood? Understanding Adult-Onset Phenylketonuria

5 min read

Phenylketonuria (PKU) is a genetic disorder typically identified through newborn screening, yet rare cases demonstrate adult-onset symptoms. It is caused by a deficiency of the enzyme phenylalanine hydroxylase (PAH), leading to a buildup of phenylalanine in the body that can cause significant health problems if untreated. The idea that can PKU start in adulthood challenges traditional medical understanding and highlights the importance of re-evaluating neurological symptoms in senior populations.

Quick Summary

Adult-onset PKU is rare but possible, particularly in individuals with milder genetic variants or those born before mandatory newborn screening, and can present with neurological and cognitive symptoms mimicking other conditions. A late diagnosis or failure to adhere to lifelong dietary treatment can trigger elevated phenylalanine levels, leading to significant health issues that require specialized care.

Key Points

  • Rare but Possible: While PKU is a genetic disorder diagnosed at birth, milder forms can remain undetected until adulthood.

  • Neurological Symptoms: Adults with late-onset PKU may experience cognitive impairment, anxiety, depression, and motor function problems.

  • Misdiagnosis Risk: Symptoms in adults can be mistaken for other neurological conditions like dementia or Parkinson's.

  • Lifelong Treatment: New evidence suggests that lifelong dietary management is essential, as stopping treatment can cause a return of symptoms.

  • Symptoms Reversible: Many adverse effects of uncontrolled phenylalanine levels in adults can be improved by resuming a strict, low-protein diet.

  • Importance of Screening: Cases of adult-onset PKU highlight the significance of widespread newborn screening and the need for continued vigilance.

In This Article

Can Phenylketonuria Manifest for the First Time in Adulthood?

While the vast majority of phenylketonuria (PKU) cases are diagnosed in infancy through universal newborn screening programs, a small number of cases are discovered later in life. The question, can PKU start in adulthood, refers to two distinct scenarios. The first involves individuals with a milder genetic form of the disorder whose symptoms did not become apparent until later in life, and the second involves individuals who were diagnosed but stopped treatment, leading to a re-emergence of symptoms. In both scenarios, the elevated phenylalanine (Phe) levels become toxic to the brain, causing a range of neurological issues.

The Genetic Basis of Adult-Onset PKU

PKU is caused by a mutation in the PAH gene, which provides instructions for making the enzyme phenylalanine hydroxylase. This enzyme is responsible for converting the amino acid phenylalanine into other substances needed by the body. The severity of PKU depends on the specific mutation and the degree of enzyme deficiency. Milder forms of the disorder, sometimes called non-PKU hyperphenylalaninemia, may result in higher residual enzyme activity, meaning that phenylalanine can be processed to some extent. This can allow individuals to go undiagnosed for many years. However, factors such as age, dietary changes, or other medical conditions can potentially push phenylalanine levels into a toxic range, triggering the onset of symptoms later in life.

Symptoms of Late-Onset PKU in Adults

When PKU manifests in adulthood, the symptoms are often neurological and can be misdiagnosed as other more common conditions, such as progressive dementia or Parkinson's disease. Common signs and symptoms of uncontrolled high phenylalanine levels in adults include:

  • Cognitive Impairment: This can manifest as memory problems, difficulty with executive function (planning, problem-solving), and a general feeling of “brain fog”.
  • Behavioral and Emotional Issues: Anxiety, depression, and social withdrawal are frequently reported by adults with elevated Phe levels.
  • Motor Function Problems: Neurological symptoms can include tremors, poor coordination, and spasticity. In rare cases, spastic paraparesis or quadriparesis has been observed.
  • Neurological Disturbances: Some individuals experience seizures or other severe neurological complications.
  • Psychiatric Symptoms: In some instances, adult PKU can present with psychiatric manifestations that are challenging to diagnose.

Diagnosis and Management of Adult-Onset PKU

Diagnosing adult-onset PKU can be challenging because its symptoms overlap with many other neurological and psychological disorders. The diagnostic process typically involves:

  1. Blood Tests: Measuring phenylalanine levels in the blood is the primary diagnostic tool. A high level of Phe with a normal or low tyrosine level is a key indicator.
  2. Genetic Testing: Confirming the presence of a PAH gene mutation can provide a definitive diagnosis.
  3. Neuroimaging: An MRI may reveal characteristic white matter abnormalities (WMAs), a common feature in uncontrolled PKU.

Management of adult-onset PKU involves a lifelong, carefully controlled, phenylalanine-restricted diet. This is often supplemented with a medical formula to ensure adequate protein intake. Regular monitoring of blood phenylalanine levels is crucial for ensuring the diet is effective. In some cases, medication such as sapropterin dihydrochloride (Kuvan®) may be used to help lower Phe levels.

The Importance of Lifelong Treatment

For many years, some medical professionals believed that the restricted diet could be discontinued after childhood. We now know this is incorrect. The brain continues to be vulnerable to the toxic effects of high phenylalanine levels throughout adulthood, and discontinuing the diet can lead to a return of symptoms and cognitive decline. Importantly, many of these adverse effects are reversible upon re-starting treatment.

Comparing PKU in Early vs. Late Diagnosis

Feature Early Diagnosis (Infancy) Late Diagnosis (Adulthood)
Screening Detected via routine newborn screening Detected after symptom onset; may have been missed during infancy
Symptom Presentation Averted by immediate treatment; potential for normal development Neurological and cognitive symptoms, often mimicking other conditions
Neurological Impact Avoidable with early, strict dietary control; minimal or no damage Potential for significant cognitive impairment and neurological damage due to prolonged exposure to high Phe levels
Treatment Challenges Establishing and maintaining a strict, lifelong diet from an early age Re-establishing a diet and treatment plan after years of normal eating; patient adherence may be difficult
Reversibility Effects are largely prevented from the start Symptoms may be reversible upon resuming treatment, but long-term cognitive deficits can persist

Conclusion: A Lifelong Concern

While the concept of PKU starting in adulthood may be surprising, it's a critical consideration for those born before the era of widespread newborn screening or those who have lapsed in their lifelong treatment. For seniors experiencing unexplained neurological symptoms, PKU should be included in the differential diagnosis, especially if a history of metabolic disease is suspected. Early diagnosis and adherence to treatment, regardless of age, are essential for managing the disorder and improving long-term quality of life. For more detailed information on living with PKU in adulthood, resources from organizations like the National Society for Phenylketonuria (NSPKU) can be incredibly valuable.


Frequently Asked Questions

Is it possible for an adult to develop PKU?

No, you cannot 'develop' PKU as an adult because it is a genetic disorder present from birth. However, individuals with a milder form of the condition may go undiagnosed until adulthood, when symptoms appear.

What are the symptoms of untreated PKU in adults?

Untreated or poorly managed PKU in adults can lead to cognitive decline, memory loss, depression, anxiety, tremors, and other neurological issues.

How does late-onset PKU differ from childhood PKU?

While the underlying cause is the same, late-onset PKU is diagnosed later in life and the symptoms are neurological and cognitive rather than the severe intellectual disability seen in untreated infants.

Can reversing the diet in adults with PKU fix the symptoms?

Yes, many of the neurological and cognitive symptoms experienced by adults with uncontrolled PKU can be reversed, at least partially, by returning to a phenylalanine-restricted diet.

Is newborn screening for PKU mandatory?

Yes, in the United States and many other countries, newborn screening for PKU is a routine and mandatory procedure. This ensures early diagnosis and treatment to prevent serious complications.

How is adult-onset PKU treated?

Treatment involves a strict, lifelong, low-phenylalanine diet, often including a medical formula, and regular monitoring of phenylalanine levels. Some patients may benefit from medication.

What if an adult with PKU was treated as a child but stopped the diet?

Even if treated in childhood, stopping the diet as an adult can lead to a rise in phenylalanine levels and the return of cognitive and neurological symptoms. Lifelong management is recommended.

Frequently Asked Questions

PKU is a genetic condition present from birth and cannot 'start' in adulthood. However, individuals with a milder form of the disorder may not experience symptoms until later in life, particularly if they were born before universal newborn screening was common.

The late appearance of PKU symptoms is typically due to a milder mutation of the PAH gene, which causes a less severe enzyme deficiency. Changes in diet or other lifestyle factors over time can lead to a buildup of phenylalanine, triggering the onset of symptoms.

Adult-onset PKU can present with a variety of neurological and psychiatric symptoms. These may include cognitive issues like 'brain fog,' memory loss, executive dysfunction, anxiety, depression, tremors, and in severe cases, seizures.

Diagnosis involves blood tests to check phenylalanine and tyrosine levels, genetic testing to identify the specific PAH gene mutation, and potentially neuroimaging like an MRI to look for white matter abnormalities.

Yes, treatment for adults involves the same principle: a lifelong, phenylalanine-restricted diet and medical formula. Some adults may also benefit from enzyme replacement therapy or other medications.

In many cases, yes. The neurological and cognitive symptoms caused by elevated phenylalanine levels are often at least partially reversible when the diet is resumed and phenylalanine levels are brought back into a healthy range.

Absolutely. Medical consensus now strongly recommends lifelong treatment. Adults who stop the diet are at risk of developing cognitive decline, mood disorders, and other neurological issues.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.